GoldenCareTM for the Treatment of Bacterial Vaginosis
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
GoldenCare is a copper intravaginal device that may be useful for the treatment of
symptomatic bacterial Vaginosis (BV). Standard treatment for BV is metronidazole. Although
the reported cure rate is as high as 90%, the recurrence rate is 58% after 12 months. The
study hypothesis is that GoldenCare will cure BV. This is a proof of concept study to collect
preliminary evidence of the safety and efficacy of GoldenCare.